Antimicrobial Defense of the Intestine

Immunity

Volumn 42, Issue 1, 2015, Pages 28-39

  Mukherjee, Sohini ^a   Hooper, Lora V ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ANTIMICROBIAL PROTEIN; BETA DEFENSIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; ENTERITIS; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; INTESTINES;

EID: 84921304368     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.12.028     Document Type: Review

References (119)

1. Aires de Sousa M., de Lencastre H. Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J.Clin. Microbiol. 2003, 41:3806-3815.
2. Ayabe T., Satchell D.P., Wilson C.L., Parks W.C., Selsted M.E., Ouellette A.J. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 2000, 1:113-118.
3. Bals R., Wilson J.M. Cathelicidins-a family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci. 2003, 60:711-720.
4. Bass R.B., Strop P., Barclay M., Rees D.C. Crystal structure of Escherichia coli MscS, a voltage-modulated and mechanosensitive channel. Science 2002, 298:1582-1587.
5. Beers S.A., Buckland A.G., Koduri R.S., Cho W., Gelb M.H., Wilton D.C. The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J.Biol. Chem. 2002, 277:1788-1793.
6. Boneca I.G., Dussurget O., Cabanes D., Nahori M.A., Sousa S., Lecuit M., Psylinakis E., Bouriotis V., Hugot J.P., Giovannini M., et al. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc. Natl. Acad. Sci. USA 2007, 104:997-1002.
7. Brandl K., Plitas G., Schnabl B., DeMatteo R.P., Pamer E.G. MyD88-mediated signals induce the bactericidal lectin RegIII γ and protect mice against intestinal Listeria monocytogenes infection. J.Exp. Med. 2007, 204:1891-1900.
8. Brandl K., Plitas G., Mihu C.N., Ubeda C., Jia T., Fleisher M., Schnabl B., DeMatteo R.P., Pamer E.G. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
9. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
10. Butterfield S.M., Lashuel H.A. Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. Angew. Chem. Int. Ed. Engl. 2010, 49:5628-5654.
11. Cadwell K., Liu J.Y., Brown S.L., Miyoshi H., Loh J., Lennerz J.K., Kishi C., Kc W., Carrero J.A., Hunt S., et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008, 456:259-263.
12. Cash H.L., Whitham C.V., Hooper L.V. Refolding, purification, and characterization of human and murine RegIII proteins expressed in Escherichia coli. Protein Expr. Purif. 2006, 48:151-159.
13. Cash H.L., Whitham C.V., Behrendt C.L., Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
14. Chairatana P., Nolan E.M. Molecular basis for self-assembly of a human host-defense peptide that entraps bacterial pathogens. J.Am. Chem. Soc. 2014, 136:13267-13276.
15. Choi S.-M., McAleer J.P., Zheng M., Pociask D.A., Kaplan M.H., Qin S., Reinhart T.A., Kolls J.K. Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia. J.Exp. Med. 2013, 210:551-561.
16. Christa L., Carnot F., Simon M.T., Levavasseur F., Stinnakre M.G., Lasserre C., Thepot D., Clement B., Devinoy E., Bréchot C. HIP/PAP is an adhesive protein expressed in hepatocarcinoma, normal Paneth, and pancreatic cells. Am. J. Physiol. 1996, 271:G993-G1002.
17. Chu H., Pazgier M., Jung G., Nuccio S.-P., Castillo P.A., de Jong M.F., Winter M.G., Winter S.E., Wehkamp J., Shen B., et al. Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 2012, 337:477-481.
18. Dickson R.P., Erb-Downward J.R., Huffnagle G.B. The role of the bacterial microbiome in lung disease. Expert Rev. Respir. Med. 2013, 7:245-257.
19. Duplantier A.J., van Hoek M.L. The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds. Front. Immunol. 2013, 4:143.
20. Dürr U.H.N., Sudheendra U.S., Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 2006, 1758:1408-1425.
21. Fahlgren A., Hammarström S., Danielsson A., Hammarström M.-L. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin. Exp. Immunol. 2003, 131:90-101.
22. Farin H.F., Karthaus W.R., Kujala P., Rakhshandehroo M., Schwank G., Vries R.G.J., Kalkhoven E., Nieuwenhuis E.E.S., Clevers H. Paneth cell extrusion and release of antimicrobial products is directly controlled by immune cell-derived IFN-γ. J.Exp. Med. 2014, 211:1393-1405.
23. Fujii G., Selsted M.E., Eisenberg D. Defensins promote fusion and lysis of negatively charged membranes. Protein Sci. 1993, 2:1301-1312.
24. Gallo R.L., Ono M., Povsic T., Page C., Eriksson E., Klagsbrun M., Bernfield M. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA 1994, 91:11035-11039.
25. Gallo R.L., Kim K.J., Bernfield M., Kozak C.A., Zanetti M., Merluzzi L., Gennaro R. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J.Biol. Chem. 1997, 272:13088-13093.
26. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3:710-720.
27. Ganz T. Antimicrobial polypeptides. J.Leukoc. Biol. 2004, 75:34-38.
28. Ghosh D., Porter E., Shen B., Lee S.K., Wilk D., Drazba J., Yadav S.P., Crabb J.W., Ganz T., Bevins C.L. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 2002, 3:583-590.
29. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J.Biol. Chem. 2003, 278:8869-8872.
30. Goto Y., Obata T., Kunisawa J., Sato S., Ivanov I.I., Lamichhane A., Takeyama N., Kamioka M., Sakamoto M., Matsuki T., et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 2014, 345:1254009.
31. Grice E.A., Segre J.A. The skin microbiome. Nat. Rev. Microbiol. 2011, 9:244-253.
32. Gudmundsson G.H., Agerberth B., Odeberg J., Bergman T., Olsson B., Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 1996, 238:325-332.
33. Gunn J.S., Ryan S.S., Van Velkinburgh J.C., Ernst R.K., Miller S.I. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect. Immun. 2000, 68:6139-6146.
34. Harder J., Schroder J.-M. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J.Biol. Chem. 2002, 277:46779-46784.
35. Harwig S.S., Tan L., Qu X.D., Cho Y., Eisenhauer P.B., Lehrer R.I. Bactericidal properties of murine intestinal phospholipase A2. J.Clin. Invest. 1995, 95:603-610.
36. Hase K., Eckmann L., Leopard J.D., Varki N., Kagnoff M.F. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 2002, 70:953-963.
37. Hill C.P., Yee J., Selsted M.E., Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 1991, 251:1481-1485.
38. Hood J.L., Jallouk A.P., Campbell N., Ratner L., Wickline S.A. Cytolytic nanoparticles attenuate HIV-1 infectivity. Antivir. Ther. (Lond.) 2013, 18:95-103.
39. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884.
40. Hooper L.V., Stappenbeck T.S., Hong C.V., Gordon J.I. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 2003, 4:269-273.
41. Hornef M.W., Pütsep K., Karlsson J., Refai E., Andersson M. Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat. Immunol. 2004, 5:836-843.
42. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cézard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
43. Iliev I.D., Funari V.A., Taylor K.D., Nguyen Q., Reyes C.N., Strom S.P., Brown J., Becker C.A., Fleshner P.R., Dubinsky M., et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012, 336:1314-1317.
44. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., Gudmundsson G. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 2001, 7:180-185.
45. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., Wei D., Goldfarb K.C., Santee C.A., Lynch S.V., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
46. Jiang Y., Lee A., Chen J., Ruta V., Cadene M., Chait B.T., MacKinnon R. X-ray structure of a voltage-dependent K+ channel. Nature 2003, 423:33-41.
47. Johansson M.E.V., Phillipson M., Petersson J., Velcich A., Holm L., Hansson G.C. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 2008, 105:15064-15069.
48. Kagan B.L., Selsted M.E., Ganz T., Lehrer R.I. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc. Natl. Acad. Sci. USA 1990, 87:210-214.
49. Kagan B.L., Jang H., Capone R., Teran Arce F., Ramachandran S., Lal R., Nussinov R. Antimicrobial properties of amyloid peptides. Mol. Pharm. 2012, 9:708-717.
50. Kaser A., Lee A.-H., Franke A., Glickman J.N., Zeissig S., Tilg H., Nieuwenhuis E.E.S., Higgins D.E., Schreiber S., Glimcher L.H., Blumberg R.S. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008, 134:743-756.
51. Kinnebrew M.A., Ubeda C., Zenewicz L.A., Smith N., Flavell R.A., Pamer E.G. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J.Infect. Dis. 2010, 201:534-543.
52. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nuñez G., Flavell R.A. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731-734.
53. Koprivnjak T., Peschel A. Bacterial resistance mechanisms against host defense peptides. Cell. Mol. Life Sci. 2011, 68:2243-2254.
54. Koslowski M.J., Kübler I., Chamaillard M., Schaeffeler E., Reinisch W., Wang G., Beisner J., Teml A., Peyrin-Biroulet L., Winter S., et al. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS ONE 2009, 4:e4496.
55. Koslowski M.J., Teltschik Z., Beisner J., Schaeffeler E., Wang G., Kübler I., Gersemann M., Cooney R., Jewell D., Reinisch W., et al. Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease. PLoS Genet. 2012, 8:e1002523.
56. Lai Y., Li D., Li C., Muehleisen B., Radek K.A., Park H.J., Jiang Z., Li Z., Lei H., Quan Y., et al. The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity 2012, 37:74-84.
57. Larrick J.W., Lee J., Ma S., Li X., Francke U., Wright S.C., Balint R.F. Structural, functional analysis and localization of the human CAP18 gene. FEBS Lett. 1996, 398:74-80.
58. Lehotzky R.E., Partch C.L., Mukherjee S., Cash H.L., Goldman W.E., Gardner K.H., Hooper L.V. Molecular basis for peptidoglycan recognition by a bactericidal lectin. Proc. Natl. Acad. Sci. USA 2010, 107:7722-7727.
59. Lichtenstein A., Ganz T., Selsted M.E., Lehrer R.I. Invitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood 1986, 68:1407-1410.
60. Loonen L.M.P., Stolte E.H., Jaklofsky M.T.J., Meijerink M., Dekker J., van Baarlen P., Wells J.M. REG3γ-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunol. 2014, 7:939-947.
61. Ma B., Forney L.J., Ravel J. Vaginal microbiome: rethinking health and disease. Annu. Rev. Microbiol. 2012, 66:371-389.
62. Madison M.N., Kleshchenko Y.Y., Nde P.N., Simmons K.J., Lima M.F., Villalta F. Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction. Infect. Immun. 2007, 75:4780-4791.
63. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1999, 1462:1-10.
64. Matsuzaki K. Control of cell selectivity of antimicrobial peptides. Biochim. Biophys. Acta 2009, 1788:1687-1692.
65. Mendez-Samperio P. Peptidomimetics as a new generation of antimicrobial agents: Current progress. Infect. Drug Resist. 2014, 7:229-237.
66. Meyer-Hoffert U., Hornef M.W., Henriques-Normark B., Axelsson L.-G., Midtvedt T., Pütsep K., Andersson M. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 2008, 57:764-771.
67. Miki T., Holst O., Hardt W.D. The bactericidal activity of the C-type lectin RegIIIβ against Gram-negative bacteria involves binding to lipid A. J.Biol. Chem. 2012, 287:34844-34855.
68. Mukherjee S., Partch C.L., Lehotzky R.E., Whitham C.V., Chu H., Bevins C.L., Gardner K.H., Hooper L.V. Regulation of C-type lectin antimicrobial activity by a flexible N-terminal prosegment. J.Biol. Chem. 2009, 284:4881-4888.
69. Mukherjee S., Zheng H., Derebe M.G., Callenberg K.M., Partch C.L., Rollins D., Propheter D.C., Rizo J., Grabe M., Jiang Q.-X., Hooper L.V. Antibacterial membrane attack by a pore-forming intestinal C-type lectin. Nature 2014, 505:103-107.
70. Murray B.E. Vancomycin-resistant enterococcal infections. N.Engl. J. Med. 2000, 342:710-721.
71. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R.A., Pestonjamasp V., Piraino J., Huttner K., Gallo R.L. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001, 414:454-457.
72. Nyberg P., Rasmussen M., Björck L. alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J.Biol. Chem. 2004, 279:52820-52823.
73. O'Neil D.A., Porter E.M., Elewaut D., Anderson G.M., Eckmann L., Ganz T., Kagnoff M.F. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J.Immunol. 1999, 163:6718-6724.
74. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
75. Peschel A., Otto M., Jack R.W., Kalbacher H., Jung G., Götz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J.Biol. Chem. 1999, 274:8405-8410.
76. Peters B.M., Shirtliff M.E., Jabra-Rizk M.A. Antimicrobial peptides: primeval molecules or future drugs?. PLoS Pathog. 2010, 6:e1001067.
77. Petnicki-Ocwieja T., Hrncir T., Liu Y.-J., Biswas A., Hudcovic T., Tlaskalova-Hogenova H., Kobayashi K.S. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. USA 2009, 106:15813-15818.
78. Pham T.A.N., Clare S., Goulding D., Arasteh J.M., Stares M.D., Browne H.P., Keane J.A., Page A.J., Kumasaka N., Kane L., et al. Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe 2014, 16:504-516. Sanger Mouse Genetics Project.
79. Pickard J.M., Maurice C.F., Kinnebrew M.A., Abt M.C., Schenten D., Golovkina T.V., Bogatyrev S.R., Ismagilov R.F., Pamer E.G., Turnbaugh P.J., Chervonsky A.V. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 2014, 514:638-641.
80. Putsep K., Axelsson L.-G., Boman A., Midtvedt T., Normark S., Boman H.G., Andersson M. Germ-free and colonized mice generate the same products from enteric prodefensins. J.Biol. Chem. 2000, 275:40478-40482.
81. Ramanan D., Tang M.S., Bowcutt R., Loke P., Cadwell K. Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity 2014, 41:311-324.
82. Reyes A., Haynes M., Hanson N., Angly F.E., Heath A.C., Rohwer F., Gordon J.I. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010, 466:334-338.
83. Robey M., O'Connell W., Cianciotto N.P. Identification of Legionella pneumophila rcp, a pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes intracellular infection. Infect. Immun. 2001, 69:4276-4286.
84. Ronald P.C., Beutler B. Plant and animal sensors of conserved microbial signatures. Science 2010, 330:1061-1064.
85. Rosenberg H.F. Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J.Biol. Chem. 1995, 270:7876-7881.
86. Salzman N.H., Ghosh D., Huttner K.M., Paterson Y., Bevins C.L. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003, 422:522-526.
87. Salzman N.H., Hung K., Haribhai D., Chu H., Karlsson-Sjöberg J., Amir E., Teggatz P., Barman M., Hayward M., Eastwood D., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 2010, 11:76-83.
88. + cells. Nat. Immunol. 2009, 10:83-91.
89. + innate lymphoid cells. Immunology 2011, 132:453-465.
90. Sass V., Schneider T., Wilmes M., Körner C., Tossi A., Novikova N., Shamova O., Sahl H.-G. Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect. Immun. 2010, 78:2793-2800.
91. Schneider T., Kruse T., Wimmer R., Wiedemann I., Sass V., Pag U., Jansen A., Nielsen A.K., Mygind P.H., Raventós D.S., et al. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 2010, 328:1168-1172. published online November 5, 2014.
92. Schroeder B.O., Wu Z., Nuding S., Groscurth S., Marcinowski M., Beisner J., Buchner J., Schaller M., Stange E.F., Wehkamp J. Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature 2011, 469:419-423.
93. Schroeder B.O., Ehmann D., Precht J.C., Castillo P.A., Küchler R., Berger J., Schaller M., Stange E.F., Wehkamp J. Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide. Mucosal Immunol. 2014, 1-11.
94. Schutte B.C., McCray P.B. [β]-defensins in lung host defense. Annu. Rev. Physiol. 2002, 64:709-748.
95. Selsted M.E., Ouellette A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 2005, 6:551-557.
96. Shanahan M.T., Carroll I.M., Grossniklaus E., White A., von Furstenberg R.J., Barner R., Fodor A.A., Henning S.J., Sartor R.B., Gulati A.S. Mouse Paneth cell antimicrobial function is independent of Nod2. Gut 2014, 63:903-910.
97. Shimada T., Park B.G., Wolf A.J., Brikos C., Goodridge H.S., Becker C.A., Reyes C.N., Miao E.A., Aderem A., Götz F., et al. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe 2010, 7:38-49.
98. Sieprawska-Lupa M., Mydel P., Krawczyk K., Wójcik K., Puklo M., Lupa B., Suder P., Silberring J., Reed M., Pohl J., et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 2004, 48:4673-4679.
99. Stelter C., Käppeli R., König C., Krah A., Hardt W.-D., Stecher B., Bumann D. Salmonella-induced mucosal lectin RegIIIβ kills competing gut microbiota. PLoS ONE 2011, 6:e20749.
100. Stowell S.R., Arthur C.M., Dias-Baruffi M., Rodrigues L.C., Gourdine J.-P., Heimburg-Molinaro J., Ju T., Molinaro R.J., Rivera-Marrero C., Xia B., et al. Innate immune lectins kill bacteria expressing blood group antigen. Nat. Med. 2010, 16:295-301.
101. Swidsinski A., Weber J., Loening-Baucke V., Hale L.P., Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J.Clin. Microbiol. 2005, 43:3380-3389.
102. Szyk A., Wu Z., Tucker K., Yang D., Lu W., Lubkowski J. Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci. 2006, 15:2749-2760.
103. Toke O. Antimicrobial peptides: new candidates in the fight against bacterial infections. Biopolymers 2005, 80:717-735.
104. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N.Engl. J. Med. 1994, 330:1247-1251.
105. Travis S.M., Anderson N.N., Forsyth W.R., Espiritu C., Conway B.D., Greenberg E.P., McCray P.B., Lehrer R.I., Welsh M.J., Tack B.F. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 2000, 68:2748-2755.
106. Vadas P., Browning J., Edelson J., Pruzanski W. Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J.Lipid Mediat. 1993, 8:1-30.
107. Vaishnava S., Behrendt C.L., Ismail A.S., Eckmann L., Hooper L.V. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. USA 2008, 105:20858-20863.
108. Vaishnava S., Yamamoto M., Severson K.M., Ruhn K.A., Yu X., Koren O., Ley R., Wakeland E.K., Hooper L.V. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011, 334:255-258.
109. van Es J.H., Jay P., Gregorieff A., van Gijn M.E., Jonkheer S., Hatzis P., Thiele A., van den Born M., Begthel H., Brabletz T., et al. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat. Cell Biol. 2005, 7:381-386.
110. VanDussen K.L., Liu T.-C., Li D., Towfic F., Modiano N., Winter R., Haritunians T., Taylor K.D., Dhall D., Targan S.R., et al. Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease. Gastroenterology 2014, 146:200-209.
111. Virgin H.W. The virome in mammalian physiology and disease. Cell 2014, 157:142-150.
112. Wehkamp J., Fellermann K., Herrlinger K.R., Baxmann S., Schmidt K., Schwind B., Duchrow M., Wohlschläger C., Feller A.C., Stange E.F. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 2002, 14:745-752.
113. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., et al. Reduced Paneth cell α-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 2005, 102:18129-18134.
114. Wilson C.L., Ouellette A.J., Satchell D.P., Ayabe T., López-Boado Y.S., Stratman J.L., Hultgren S.J., Matrisian L.M., Parks W.C. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999, 286:113-117.
115. Wilson S.S., Wiens M.E., Smith J.G. Antiviral mechanisms of human defensins. J.Mol. Biol. 2013, 425:4965-4980.
116. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
117. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
118. Zanetti M. The role of cathelicidins in the innate host defenses of mammals. Curr. Issues Mol. Biol. 2005, 7:179-196.
119. Zhang Y., Lu W., Hong M. The membrane-bound structure and topology of a human α-defensin indicate a dimer pore mechanism for membrane disruption. Biochemistry 2010, 49:9770-9782.